Neo Ivy Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-272
| Closed | -$22K | – | 545 |
|
|
2022
Q1 | $22K | Buy |
272
+229
| +533% | +$18.5K | 0.02% | 424 |
|
|
2021
Q4 | $9K | Sell |
43
-25
| -37% | -$5.23K | 0.01% | 389 |
|
|
2021
Q3 | $24K | Buy |
+68
| New | +$24K | 0.03% | 382 |
|
|
2021
Q1 | – | Sell |
-309
| Closed | -$79K | – | 584 |
|
|
2020
Q4 | $79K | Buy |
+309
| New | +$79K | 0.09% | 272 |
|
|
2020
Q3 | – | Sell |
-68
| Closed | -$24K | – | 565 |
|
|
2020
Q2 | $24K | Sell |
68
-89
| -57% | -$31.4K | 0.03% | 382 |
|
|
2020
Q1 | $42K | Buy |
+157
| New | +$42K | 0.07% | 330 |
|
|
2019
Q1 | – | Sell |
-1,274
| Closed | -$628K | – | 369 |
|
|
2018
Q4 | $628K | Buy |
+1,274
| New | +$628K | 0.49% | 77 |
|